Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Convertible Preferred Stock and Stockholders' Equity (Deficit)

v3.22.2
Condensed Consolidated Statement of Changes in Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock [Member]
Preferred Stock [Member]
Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Accumulated Deficit [Member]
Total [Member]
Beginning Balance at Dec. 31, 2020 $ 62,025   $ 137,497 $ 4 $ 5,538 $ (1,450) $ (79,564) $ (75,472)
Beginning Balance, Shares at Dec. 31, 2020   107,592,801   39,510,108   483,479    
Exercise of common stock options 356       356     356
Exercise of common stock options, Shares       714,170        
Stock-based compensation expense 1,194       1,194     1,194
Exercise of Series D warrants 100 $ 100            
Exercise of Series D warrants, Shares   20,037            
Net income (loss) and comprehensive income (loss) (10,019)           (10,019) (10,019)
Ending Balance at Mar. 31, 2021 53,656   137,597 $ 4 7,088 $ (1,450) (89,583) (83,941)
Ending Balance, Shares at Mar. 31, 2021   107,612,838   40,224,278   483,479    
Beginning Balance at Dec. 31, 2020 62,025   137,497 $ 4 5,538 $ (1,450) (79,564) (75,472)
Beginning Balance, Shares at Dec. 31, 2020   107,592,801   39,510,108   483,479    
Net income (loss) and comprehensive income (loss) (21,109)              
Ending Balance at Jun. 30, 2021 46,553   137,952 $ 4 10,720 $ (1,450) (100,673) (91,399)
Ending Balance, Shares at Jun. 30, 2021   107,683,977   40,506,087   483,479    
Beginning Balance at Mar. 31, 2021 53,656   137,597 $ 4 7,088 $ (1,450) (89,583) (83,941)
Beginning Balance, Shares at Mar. 31, 2021   107,612,838   40,224,278   483,479    
Exercise of common stock options 62       62     62
Exercise of common stock options, Shares       102,237        
Stock-based compensation expense 1,777       1,777     1,777
Exercise of Series D warrants 355 $ 355            
Exercise of Series D warrants, Shares   71,139            
Exercise of common stock warrants, net of shares withheld for exercise 1,793       1,793     1,793
Exercise of common stock warrants, net of shares withheld for exercise, Shares       179,572        
Net income (loss) and comprehensive income (loss) (11,090)           (11,090) (11,090)
Ending Balance at Jun. 30, 2021 46,553   137,952 $ 4 10,720 $ (1,450) (100,673) (91,399)
Ending Balance, Shares at Jun. 30, 2021   107,683,977   40,506,087   483,479    
Beginning Balance at Dec. 31, 2021 244,169   0 $ 19 319,859 $ 0 (75,709) 244,169
Beginning Balance, Shares at Dec. 31, 2021   0   185,993,058   0    
Exercise of common stock options 580       580     580
Exercise of common stock options, Shares       942,836        
Stock vested under compensation plan less shares withheld to cover taxes       182,066        
Stock-based compensation expense 4,285       4,285     4,285
Earnout stock-based compensation expense 1,137       1,137     1,137
Net income (loss) and comprehensive income (loss) 4,239           4,239 4,239
Ending Balance at Mar. 31, 2022 254,410   0 $ 19 325,861 (71,470) 254,410
Ending Balance, Shares at Mar. 31, 2022   0   187,117,960   0    
Beginning Balance at Dec. 31, 2021 244,169   0 $ 19 319,859 $ 0 (75,709) 244,169
Beginning Balance, Shares at Dec. 31, 2021   0   185,993,058   0    
Issuance of Common Stock in connection with acquisitions 2,354              
Net income (loss) and comprehensive income (loss) 8,314              
Ending Balance at Jun. 30, 2022 266,352   0 $ 19 333,728 $ 0 (67,395) 266,352
Ending Balance, Shares at Jun. 30, 2022   0   188,482,934   0    
Beginning Balance at Mar. 31, 2022 254,410   0 $ 19 325,861 (71,470) 254,410
Beginning Balance, Shares at Mar. 31, 2022   0   187,117,960   0    
Exercise of common stock options 916       916     916
Exercise of common stock options, Shares       443,712        
Stock vested under compensation plan less shares withheld to cover taxes       319,165        
Number of Shares, Vested Value 315       (315)     (315)
Stock-based compensation expense 4,005       4,005     4,005
Earnout stock-based compensation expense 907       907   907
Issuance of Common Stock in connection with acquisitions 2,354       2,354     2,354
Issuance of Common Stock in connection with acquisitions, shares       602,097        
Net income (loss) and comprehensive income (loss) 4,075           4,075 4,075
Ending Balance at Jun. 30, 2022 $ 266,352   $ 0 $ 19 $ 333,728 $ 0 $ (67,395) $ 266,352
Ending Balance, Shares at Jun. 30, 2022   0   188,482,934   0